Table 2. Baseline demographics and mortality risk by demographic subgroup for EBOV positive patients with known symptom onset date.
| n (%) | Case Fatality Ratios* (%) | Mortality Risk from Survival Curves | |||
|---|---|---|---|---|---|
| Hazard Ratios | 95% CI Lower | 95% CI Upper | |||
| All | 297 (100.0) | 58.36 | - | - | - |
| Sex* | |||||
| Male | 127 (42.76) | 60.80 | 1.12 | 0.83 | 1.51 |
| Female | 170 (57.24) | 56.55 | - | - | - |
| Age Category (years)** | |||||
| 0 to 4 | 21 (7.07) | 85.71 | 3.65 | 1.90 | 7.05 |
| 5 to 14 | 41 (13.80) | 50.00 | 1.39 | 0.73 | 2.63 |
| 15 to 24 | 46 (15.49) | 40.00 | - | - | - |
| 25 to 34 | 56 (18.86) | 50.91 | 1.29 | 0.71 | 2.34 |
| 35 to 44 | 62 (20.88) | 63.93 | 1.89 | 1.08 | 3.30 |
| ≥ 45 | 71 (23.91) | 67.61 | 1.89 | 1.10 | 3.25 |
| Country | |||||
| Sierra Leone | 123 (41.41) | 65.55 | 1.36 | 1.00 | 1.83 |
| Liberia | 174 (58.59) | 53.45 | - | - | - |
| Year | |||||
| 2014 | 212 (72.35) | 56.13 | - | - | |
| 2015 | 81 (27.65) | 64.2 | 1.32 | 0.83 | 1.51 |
* Not including Transferred patients (n = 4)
** Missing values not included